93 related articles for article (PubMed ID: 21382628)
1. [Factors involved in resistance to human immunodeficiency virus infection].
Restrepo C; Rallón NI; Benito JM
Med Clin (Barc); 2011 Nov; 137(13):600-4. PubMed ID: 21382628
[TBL] [Abstract][Full Text] [Related]
2. Host factors involved in low susceptibility to HIV infection.
Restrepo C; Rallón NI; Carrillo J; Soriano V; Blanco J; Benito JM
AIDS Rev; 2011; 13(1):30-40. PubMed ID: 21412387
[TBL] [Abstract][Full Text] [Related]
3. Genetic and immune determinants of immune activation in HIV-exposed seronegative individuals and their role in protection against HIV infection.
Fenizia C; Rossignol JF; Clerici M; Biasin M
Infect Genet Evol; 2018 Dec; 66():325-334. PubMed ID: 29258786
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons.
Bernard NF; Yannakis CM; Lee JS; Tsoukas CM
J Infect Dis; 1999 Mar; 179(3):538-47. PubMed ID: 9952359
[TBL] [Abstract][Full Text] [Related]
5. Genetic correlates of protection against HIV infection: the ally within.
Piacentini L; Biasin M; Fenizia C; Clerici M
J Intern Med; 2009 Jan; 265(1):110-24. PubMed ID: 19093964
[TBL] [Abstract][Full Text] [Related]
6. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals.
Montoya CJ; Velilla PA; Chougnet C; Landay AL; Rugeles MT
Clin Immunol; 2006 Aug; 120(2):138-46. PubMed ID: 16624619
[TBL] [Abstract][Full Text] [Related]
7. [Soluble factors with inhibitory activity against type 1 Human Immunodeficiency Virus].
Zapata W; Montoya CJ; Rugeles MT
Biomedica; 2006 Sep; 26(3):451-66. PubMed ID: 17176009
[TBL] [Abstract][Full Text] [Related]
8. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals.
Boulet S; Sharafi S; Simic N; Bruneau J; Routy JP; Tsoukas CM; Bernard NF
AIDS; 2008 Mar; 22(5):595-9. PubMed ID: 18317000
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of human natural resistance to HIV: a summary of ten years of research in the Colombian population.
Rugeles MT; Velilla PA; Montoya CJ
Biomedica; 2011 Jun; 31(2):269-80. PubMed ID: 22159545
[TBL] [Abstract][Full Text] [Related]
10. Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals.
Restrepo C; Rallón NI; del Romero J; Rodríguez C; Hernando V; López M; Peris A; Lozano S; Sempere-Ortells JM; Soriano V; Benito JM
J Immunol; 2010 Jul; 185(2):982-9. PubMed ID: 20543099
[TBL] [Abstract][Full Text] [Related]
11. Suppressed cellular alloimmune responses in HIV-exposed seronegative female sex workers.
Jennes W; Evertse D; Borget MY; Vuylsteke B; Maurice C; Nkengasong JN; Kestens L
Clin Exp Immunol; 2006 Mar; 143(3):435-44. PubMed ID: 16487242
[TBL] [Abstract][Full Text] [Related]
12. Defining the genital immune correlates of protection against HIV acquisition: co-infections and other potential confounders.
Kaul R; Ball TB; Hirbod T
Sex Transm Infect; 2011 Mar; 87(2):125-30. PubMed ID: 21228419
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1.
Liu H; Hwangbo Y; Holte S; Lee J; Wang C; Kaupp N; Zhu H; Celum C; Corey L; McElrath MJ; Zhu T
J Infect Dis; 2004 Sep; 190(6):1055-8. PubMed ID: 15319853
[TBL] [Abstract][Full Text] [Related]
14. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.
Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB
Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258
[TBL] [Abstract][Full Text] [Related]
15. Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals.
Kulkarni PS; Butera ST; Duerr AC
AIDS Rev; 2003; 5(2):87-103. PubMed ID: 12876898
[TBL] [Abstract][Full Text] [Related]
16. Stromal cell-derived factor (SDF) 1-3'A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais.
Tiensiwakul P
Intervirology; 2004; 47(2):87-92. PubMed ID: 15192272
[TBL] [Abstract][Full Text] [Related]
17. Host genetic factors that control immune responses to retrovirus infections.
Miyazawa M; Tsuji-Kawahara S; Kanari Y
Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women.
Alimonti JB; Koesters SA; Kimani J; Matu L; Wachihi C; Plummer FA; Fowke KR
J Infect Dis; 2005 Jan; 191(1):20-4. PubMed ID: 15592998
[TBL] [Abstract][Full Text] [Related]
19. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
20. Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells.
Bomsel M; Pastori C; Tudor D; Alberti C; Garcia S; Ferrari D; Lazzarin A; Lopalco L
AIDS; 2007 Jan; 21(1):13-22. PubMed ID: 17148963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
